Niacinamide and sea daffodils-based bright healthy radiance product range for dark spots: a survey of Indian dermatologists' views and patient insights
DOI:
https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20242288Keywords:
Hyperpigmentation, Dark spots, Niacinamide, Sea daffodil, Skin radianceAbstract
Background: Niacinamide has demonstrated its ability to treat dark spots in various studies. The present study evaluated the perspectives and experiences of healthcare professionals (HCPs) and patients with the niacinamide and sea daffodils-based bright healthy radiance product range for dark spots.
Methods: This study was part of a survey series focusing on various dermatology products across India. The study involved over 1000 registered HCPs including dermatologists, pediatricians, and cosmetologists nationwide. A total of 203 HCPs participated in the survey on the niacinamide and sea daffodils-based product range. A well-structured questionnaire with 15 questions was used to collect the data and the responses were recorded by the HCPs.
Results: Out of the total of 1086 individuals who participated in the survey, majority were females (774, 71.2%). Most HCPs reported that nearly 15-30% of their patients present with dark spots. A vast majority of individuals reported extreme satisfaction with the use of niacinamide and sea daffodils-based bright healthy radiance product range (493, 45.5%) and rated its effectiveness as excellent (511, 47.2%). HCPs reported that most patients showed major improvement in skin brightness (529, 48.7%), while the rest of them (418, 38.4%; 137, 12.6%) experienced good and satisfactory improvement respectively. Importantly, an even skin tone was achieved in most of the patients (492, 45.8%) after the application of the product range.
Conclusions: A personalized approach of using niacinamide and sea daffodil-based products according to the patient's skin types and skin conditions is essential to remove blemishes and dark spots and improve skin brightness.
References
Bino SD, Duval C, Bernerd F. Clinical and Biological Characterization of Skin Pigmentation Diversity and Its Consequences on UV Impact. Int J Mol Sci. 2018;9:2668.
Maymone MBC, Neamah HH, Wirya SA, Patzelt NM, Zancanaro PQ, Vashi NA. Sun-protective behaviors in patients with cutaneous hyperpigmentation: A cross-sectional study. J Am Acad Dermatol 2017;76(5):841-6.
Katiyar S, Khozema S, Meenu R, Sharma A, Singh SK, Singh N. A systematic review on melasma: A review. Int J Cur Bio Med Sci. 2011;1(2):63-8.
Arrowitz C, Schoelermann AM, Mann T, Jiang LI, Weber T, Kolbe L. Effective Tyrosinase Inhibition by Thiamidol Results in Significant Improvement of Mild to Moderate Melasma. J Invest Dermatol 2019;139(8):1691-8.
Cardinali G, Bolasco G, Aspite N, Lucania G, Lotti LV, Torrisi MR, et al. Melanosome Transfer Promoted by Keratinocyte Growth Factor in Light and Dark Skin-Derived Keratinocytes. J Invest Dermatol 2008;128(3):558-67.
American Society for Dermatologic Surgery. Age Spots. Available at: https://www.asds.net/skin-experts/skin-conditions/age-spots. Accessed on 19 April 2024.
Bandyopadhyay D. Topical treatment of melasma. Ind J Dermatol. 2009;54(4):303-9.
Bissett DL, Robinson LR, Raleigh PS, Miyamoto K, Hakozaki T, Li J, et al. Reduction in the appearance of facial hyperpigmentation by topical N-undecyl-10-enoyl-L-phenylalanine and its combination with niacinamide. J Cosmet Dermatol. 2009;8(4):260-6.
Desai SR. Hyperpigmentation Therapy: A Review. J Clin Aesthet Dermatol. 2014;7(8):13-7.
Hakozaki T, Minwalla L, Zhuang J, Chhoa M, Matsubara A, Miyamoto K, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol. 2002;147(1):20-31.
Nakamura M, Morita A, Seité S, Haarmann-Stemmann T, Grether-Beck S, Krutmann J. Environment-induced lentigines: formation of solar lentigines beyond ultraviolet radiation. Exp Dermatol. 2015;24(6):407-11.
Navarrete-Solís J, Castanedo-Cázares JP, Torres-Álvarez B, Oros-Ovalle C, Fuentes-Ahumada C, González FJ, et al. A Double-Blind, Randomized Clinical Trial of Niacinamide 4% versus Hydroquinone 4% in the Treatment of Melasma. Dermatol Res Pract. 2011;2011:379173.
Gedouin A, Vallee R, Morvan PY. Use of Pancratium maritimum extract as cosmetic antioxidizing agent and/or melanogenesis inhibitor in cosmetic composition e.g. to prevent/fight against the signs of skin aging, and for depigmenting of the skin, body hair and/or hair. FR2926220A1, 2009. Available at: https://patents.google.com/patent/ FR2926220A1/en. Accessed on 27 July 2024.
Sarkar R, Arora P, Garg KV. Cosmeceuticals for Hyperpigmentation: What is Available? J Cutan Aesthet Surg. 2013;6(1):4-11.
Matts P, Oblong J, Bissett DL. A Review of the range of effects of niacinamide in human skin. Int Fed Soc Cosmet Chem Mag. 2002;5:285-9.
Morvan PY, Pentecouteau L, Vallée R. Effect of a marine plant extract on skin melanogenesis. 21st IFSCC Conferences 2011. Available at: https://www.researchgate.net/publication/279952310_Effect_of_a_marine_plant_extract_on_skin_melanogenesis. Accessed on 27 July 2024.
Boo YC. Mechanistic Basis and Clinical Evidence for the Applications of Nicotinamide (Niacinamide) to Control Skin Aging and Pigmentation. Antioxidants (Basel). 2021;10(8):1315.
